|
FY2026
12 months to Jul 31, 2026
|
FY2025
12 months to Jul 31, 2025
|
FY2024
12 months to Jul 31, 2024
|
FY2023
12 months to Jul 31, 2023
|
FY2022
12 months to Jul 31, 2022
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net profit/(loss) | |||||
| Net profit/(loss) | |||||
| Impairment loss | |||||
| Convertible notes interest accrued for conversion | |||||
| Original initial discount and legal processing fees | |||||
| Convertible Notes Write off | |||||
| Loan Payable write off | |||||
| Accounts payable write off | |||||
| Deposit & Prepayments | |||||
| Extinguishment of convertible notes | |||||
| Extinguishment of debt | |||||
| Settlement of accounts payable | |||||
| Settlement of accounts payable | |||||
| Royalty interest depletion | |||||
| Changes in assets and liabilities: | |||||
| Accounts payable and accrued expenses | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Software development | |||||
| Royal interest acquisition | |||||
| Net cash used in investing activities | |||||
| Proceeds from Convertible bond | |||||
| Proceeds from Loan | |||||
| Repayment made to Loan balance | |||||
| Convertible notes repayment | |||||
| Proceeds from Issuance of preferred shares | |||||
| Proceeds from Issuance of common shares | |||||
| Proceeds provided by additional paid in capital | |||||
| Net cash from financing activities | |||||
| Net change in cash | |||||
| Cash at beginning of year | |||||
| Cash at end of year | |||||
| Non-cash activities | |||||
| Issuing common stock and preferred stock in connection with convertible notes | |||||
| Convertible notes payable and accounts payable repayment made by shareholder on behalf of the Company | |||||
| Expenses payment made by a stockholder on behalf of the Company as paid in capital | |||||
Loading...